Bladder Cancer - Results from #40

REVIEW UroToday

Predicting response to intravesical BCG in high-risk non-muscle invasive bladder cancer using an artificial intelligence-powered pathology assay: development and validation in an international 12 center cohort. October 11, 2024

Novel intravesical therapies and delivery systems for the management of bladder cancer. October 11, 2024

Perioperative Complications and In-Hospital Mortality in Paraplegic Radical Cystectomy Patients. October 10, 2024

Impact of DNA Repair Deficiency in the Evolving Treatment Landscape of Bladder Cancer. October 10, 2024

Dose-escalated Adaptive Radiotherapy for Bladder Cancer: Results of the Phase 2 RAIDER Randomised Controlled Trial. October 10, 2024

Management options for node-positive muscle-invasive bladder cancer. October 9, 2024

Prognostic Impact of Bone Metastasis in Patients With Metastatic Urothelial Carcinoma Treated With Durvalumab With or Without Tremelimumab in the DANUBE Study. October 9, 2024

A Single Institution Experience in the Management of Localized Neuroendocrine Carcinoma of the Bladder. October 9, 2024

FGFR Inhibition in Urothelial Carcinoma. October 9, 2024

Treatment Preferences and Tradeoffs Among Patients with Locally Advanced or Metastatic Urothelial Carcinoma - Expert Commentary October 8, 2024

Survival Rates in Trimodal Therapy Versus Radiotherapy in Urothelial Carcinoma of Urinary Bladder. October 7, 2024

The genomic and transcriptomic landscape of metastastic urothelial cancer. October 7, 2024

Quantification of micropapillary component on transurethral resection is associated with likelihood of occult lymph node metastasis at radical cystectomy. October 7, 2024

Does the Extent of Transurethral Resection after Radiation Therapy Impact Survival Outcomes in Muscle-Invasive Bladder Cancer - Expert Commentary October 4, 2024

Bladder Adjuvant RadioTherapy (BART): Acute and Late Toxicity from a Phase III Multicentre Randomized Controlled Trial: Acute and late toxicity in BART RCT. October 4, 2024

Benefit of Whole-Pelvis Radiation for Patients With Muscle-Invasive Bladder Cancer: An Inverse Probability Treatment Weighted Analysis. October 4, 2024

Tranexamic Acid During Radical Cystectomy: A Randomized Clinical Trial. October 4, 2024

Gut Microbiota Influence Bladder Tumour Development October 3, 2024

Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer October 3, 2024

The role of radical cystectomy and lymphadenectomy in the management of bladder cancer with clinically positive lymph node involvement. October 3, 2024

Page 3 of 517